Keen Therapeutics Revenue

Biotechnology Research • Gusu District, Jiangsu, China • 1-10 Employees

Keen Therapeutics revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Key Contacts at Keen Therapeutics

Angela Miao

Sr. Director - Hr & Operation Management

Yikai Wang

Founder, President, Ceo

Company overview

Headquarters	Gusu District, Jiangsu, China
NAICS	541714
Founded	2020
Employees	1-10

About Keen Therapeutics

Keen Therapeutics was recently founded aiming to become the next generation biotech in China. The Company is led by a group of spirited chemical biologist, biophysicist, immunologist, computational chemist, and algorithm engineer. Enabled by first-principle-based computational methods, the Company focuses on challenging targets/pathways to provide innovative cancer therapies. Through collaboration with niche CROs that are more focused and efficient, the Company tries to minimize the time and cost for pre-clinical discovery. The Company has made dedicated efforts and some progress in the area of cancer metabolism including ferroptosis. It is expected to nominate the first pre-clinical candidate by the end of 2022.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Senior

C-Suite

Entry

Employees by Department

Keen Therapeutics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Keen Therapeutics has never raised funding before.

Frequently asked questions

Keen Therapeutics is located in Gusu District, Jiangsu, CN.

Keen Therapeutics generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Keen Therapeutics has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Keen Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Keen Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Keen Therapeutics

Angela Miao

Sr. Director - Hr & Operation Management

Yikai Wang

Founder, President, Ceo

4.8

40,000 users